Oncolytics Biotech
ONCY
#9651
Rank
S$0.12 B
Marketcap
S$1.07
Share price
-3.60%
Change (1 day)
-32.53%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : S$7.08 Million

According to Oncolytics Biotech 's latest financial reports the company has S$7.08 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$6.67 M-55.65%
2024-12-31S$15.05 M-56.67%
2023-12-31S$34.75 M9.49%
2022-12-31S$31.74 M-27.44%
2021-12-31S$43.75 M35.08%
2020-12-31S$32.38 M121.82%
2019-12-31S$14.6 M6.26%
2018-12-31S$13.74 M9.15%
2017-12-31S$12.58 M-17.22%
2016-12-31S$15.2 M-42.79%
2015-12-31S$26.58 M44.29%
2014-12-31S$18.42 M-43.13%
2013-12-31S$32.39 M23.75%
2012-12-31S$26.17 M-40.8%
2011-12-31S$44.21 M-19.99%
2010-12-31S$55.25 M20.76%
2009-12-31S$45.75 M193.3%
2008-12-31S$15.6 M-57.42%
2007-12-31S$36.63 M0.86%
2006-12-31S$36.32 M-37.29%
2005-12-31S$57.92 M25.84%
2004-12-31S$46.03 M69.3%
2003-12-31S$27.18 M196.53%
2002-12-31S$9.16 M-47.33%
2001-12-31S$17.4 M-14.52%
2000-12-31S$20.36 M289.4%
1999-12-31S$5.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
S$6.81 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.53 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$1.25 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$35.87 M 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$4.82 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$99.87 M 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA